Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000933430-22-000001
Filing Date
2022-01-24
Accepted
2022-01-24 16:03:11
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT clsd13g4.txt SC 13G/A 7105
  Complete submission text file 0000933430-22-000001.txt   8436
Mailing Address 1603 ORRINGTON AVE., STE 900 EVANSTON IL 60201
Business Address
WHITMORE BRADFORD T (Filed by) CIK: 0000933430 (see all company filings)

State of Incorp.: IL | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Subject) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89527 | Film No.: 22549331
SIC: 2834 Pharmaceutical Preparations